|Articles|May 1, 2001

May 2001
Volume 7
Issue 5

Development and Validation of the Pharmaceutical Care Satisfaction Questionnaire

Author(s)Greta K. Gourley, PharmD, PhD, Dick R. Gourley, PharmD, Elaine La Monica Rigolosi, EdD, JD

Download PDF: Development and Validation of the Pharmaceutical Care Satisfaction Questionnaire

Articles in this issue

over 25 years ago

Article

Patient's Knowledge of Health Plan Coverage and Satisfaction with Care

over 25 years ago

Article

Health Insurance, Primary Care, and Preventable Hospitalization of Children in a Large State

over 25 years ago

Article

Impact of HMO Ownership on Management Processes and Utilization Outcomes

over 25 years ago

Article

Diabetes Mellitus in Managed Care: Complications and Resource Utilization

over 25 years ago

Article

Impact of Managed MediCal on California Family Practice Programs

over 25 years ago

Article

Treatment of Hypertension in a Managed Care Setting

over 25 years ago

Article

Total Cost Comparison of 2 Biopsy Methods for Nonpalpable Breast Lesions

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Development and Validation of the Pharmaceutical Care Satisfaction Questionnaire

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Student Mental Health, Success Tied to Future Health and Affordability

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South